3 weeks Lilly’s Q3 Earnings Miss, Mounjaro, Zepbound Disappoint, Stock TanksZacks
Eli Lilly misses third-quarter estimates for earnings and sales. Mounjaro and Zepbound sales also miss estimates. Stock declines 11%.
XEli Lilly misses third-quarter estimates for earnings and sales. Mounjaro and Zepbound sales also miss estimates. Stock declines 11%.
X